Cite
HARVARD Citation
van den Heuvel, L. et al. (n.d.). Eculizumab therapy monitoring: Residual hemolysis in alternative pathway test is not caused by C5 activity. Molecular immunology. pp. 226-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
van den Heuvel, L. et al. (n.d.). Eculizumab therapy monitoring: Residual hemolysis in alternative pathway test is not caused by C5 activity. Molecular immunology. pp. 226-. [Online].